Name
PD13-08 - First-in-human safety and activity of ARV-471, a novel PROTAC® estrogen receptor degrader, in ER+/HER2- locally advanced or metastatic breast cancer
Date & Time
Tuesday, December 7, 2021
Speakers
Virtual Session Link